'Novel Technologies' launch meeting, April 2016
From left to right:
Top row: Dr. Subhamay Ghosh, Prof. Luis Mur - Scientific Lead, Prof. Keir Lewis - Clinical Lead, Denisa Asandei, Adrian Mironas, Dr. Priya Sai-Giridhar
Bottom row: Dr. Tim Tasibey, Dr. Kirsty Hett, Rachel Paes De Araujo
Novel technologies for diagnosing and monitoring pulmonary diseases
IRAS ID 187325
This is a collaborative study between academia and the NHS which seeks to harness the latest scientific advances to improve the care of patients with different respiratory diseases.
We are indebted to the many patients who have contributed to, and continue to contribute to this study.
This website is for you to see how you are aiding important clinical advances and allows you to contact us should you wish.
The 'Novel Technologies' study was launched in April of 2016 and it focuses on identifying important biomarkers in saliva, sputum, serum and pleural fluids which are linked to:
The presence of lung cancer
A particular stage of lung cancer
A particular type of lung cancer; (e.g. Non-small cell lung cancer [NSCLC]; small cell lung cancer [SCLC])
COPD disease status and the triggering of exacerbation (a flare-up or episode when your breathing gets markedly worse)
informing the treatment of sleep apnoea
Professor Keir Lewis
COPD, Lung Cancer and smart database development
Keir Lewis is Professor at Swansea University, Medical Director of Respiratory Innovation Wales and Consultant in Respiratory Medicine at Hywel Dda University Health Board. He is the Clinical Lead for the Novel Technologies Project and helps to frame new questions on biomarkers and helps identify and recruit patients with various lung conditions into the various studies.
Respiratory research assistant
Sarah Bowen Respiratory Research Assistant at Prince Philip Hospital Hywel Dda University Health Board. She provides day to day admin support for the Novel Technologies project, site file maintenance and co-ordinating sample transfers.
Professor Luis Mur
Prof. Mur is Director of Reseach for Biology and Health at Aberystwyth University. He uses the latest 'omic approaches to develop our knowledge of a range of pathologies. He is visiting Professor of UNESP (Sao Paulo) in Brazil, the University of Silesia in Poland and Northwest University in China. He has "recognised foreign expert" status at Shandong University, China.